Powered Research, a leading preclinical CRO specializing in non-GLP models, has launched its oncology models and research services tailored to meet the unique needs of life science R&D companies. This ...

In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...

According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 14 Billion by 2035 at ...

Driven EcosystemsDublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Test Techniques (Flow ...

The US Single-Cell Analysis Market is projected to reach US$2,695.3 million by 2029 from an estimated US$1,378.6 million in 2024, at a CAGR ...

The need for tumour biopsies could be eliminated by 2035 with a simple blood test to detect cancer developed by Manchester ...

Mass cytometry by time-of-flight (CyTOF) is a newly developed technology that can profile the composition and number of immune cells.25–27 To test the value of peripheral blood immune cells in tumour ...

Enzo’s innovations are changing the story of HPV. The FLOWSCRIPT® Assay employs a novel, flow cytometry-based, in situ hybridization technique, utilizing a cocktail of probes specific to multiple ...

Department of Materials Science and Engineering, College of Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea Research Institute of Advanced Materials, ...

Department of Chemistry, York University, Toronto, Ontario, Canada M3J 1P3 Center for Research on Biomolecular Interactions, York University, Toronto, Ontario, Canada M3J 1P3 Department of Psychology, ...